This review discusses the impact of recent publications on pathophysiologic concepts and
on practical aspects of acute mountain sickness (AMS). Magnetic resonance imaging …

Abstract Kayser, Bengt, Lionel Dumont, Christopher Lysakowski, Christophe Combescure,
Guy Haller, Martin R. Tramèr. Reappraisal of acetazolamide for the prevention of acute …

The pathophysiology of acute mountain sickness (AMS) is unknown. One hypothesis is that
hypoxia induces biochemical changes that disrupt the blood-brain barrier (BBB) and …

Acute mountain sickness (AMS) describes a constellation of symptoms that is usually self-
limited and benign. However, it may impair judgement and physical abilities at high altitudes …

The diagnosis, treatment and prevention of high altitude cerebral edema (HACE) are fairly
well established. The major unresolved issues are 1) the pathophysiology, 2) the individual …

Background Acetazolamide has been reported to be effective in the prevention of acute
mountain sickness (AMS). Our aim was to conduct a systematic review of randomized …

Abstract Tissot van Patot, Martha C., Guy Leadbetter III, Linda E. Keyes, Kirsten M.
Maakestad, Sheryl Olsen, and Peter Hackett. High Alt. Med. & Biol. 9: 289–293, 2008 …

The objective of this study was to determine the efficacy of low-dose acetazolamide (125 mg
twice daily) for the prevention of acute mountain sickness (AMS). The design was a …

At any point 1–5 days following ascent to altitudes≥ 2500 m, individuals are at risk of
developing one of three forms of acute altitude illness: acute mountain sickness, a syndrome …

Acute mountain sickness (AMS) affects, to varying degrees, all travelers to high altitudes
(elevations greater than 5280 feet). In a small percentage of patients, AMS can lead to high …